Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Price, 1979, Liver and biliary diseases-pathophysiology, diagnosis, management, 381
Ishiguro, 1991, Complete amino acid sequence of human liver cytosolic alanine aminotransferase (GPT) determined by a combination of conventional and mass spectral methods, Biochemistry, 30, 10451, 10.1021/bi00107a013
Sohocki, 1997, Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA and genomic sequences, and polymorphic sites, Genomics, 40, 247, 10.1006/geno.1996.4604
Fraser, 1991, Biological variation in clinical chemistry: an update: collated data, 1988-1991, Arch Pathol Lab Med, 116, 916
Cordoba, 1999, Diurnal variation of serum alanine transaminase activity in chronic liver disease, HEPATOLOGY, 28, 1724, 10.1002/hep.510280640
Williams, 1988, Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosis, Gastroenterology, 95, 734, 10.1016/S0016-5085(88)80022-2
Sheth, 1998, AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection, Am J Gastroenterol, 93, 44, 10.1111/j.1572-0241.1998.044_c.x
Prati, 2002, Updated definitions of healthy ranges for serum alanine aminotransferase levels, Ann Intern Med, 137, 1, 10.7326/0003-4819-137-1-200207020-00006
Siest, 1975, Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations and reference values, Clin Chem, 21, 1077, 10.1093/clinchem/21.8.1077
Salvaggio, 1991, Body mass index and liver enzyme activity in serum, Clin Chem, 37, 720, 10.1093/clinchem/37.5.720
Piton, 1998, Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C, HEPATOLOGY, 27, 1213, 10.1002/hep.510270505
Nuttall, 1968, Creatinine kinase and glutamic oxoloacetic transaminase activity in serum: kinetics of change with exercise and effect of physical conditioning, J Lab Clin Med, 51, 257
Dufour, 1998, Effects of habitual exercise on routine laboratory tests, Clin Chem, 44, 136
Kundrotas, 1993, Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors, Dig Dis Sci, 39, 2145, 10.1007/BF01299887
Mathiesen, 1999, The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients, Scand J Gastroenterol, 34, 85, 10.1080/00365529950172880
Ludwig, 1980, Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease, Mayo Clinic Proc, 55, 434
Ruhl, 2003, Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States, Gastroenterology, 124, 71, 10.1053/gast.2003.50004
Bacon, 1994, Non-alcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6
Hedley, 2004, Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.[see comment], JAMA, 291, 2847, 10.1001/jama.291.23.2847
Bray, 2006, Epidemiology, trends, and morbidities of obesity and the metabolic syndrome, Endocrine, 29, 109, 10.1385/ENDO:29:1:109
Kerner, 2005, Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome, Arterioscler Thromb Vasc Biol, 25, 193, 10.1161/01.ATV.0000148324.63685.6a
Kunde, 2005, Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women, HEPATOLOGY, 42, 650, 10.1002/hep.20818
Kim, 2001, Outcome of hospital care of liver disease associated with hepatitis C in the United States, HEPATOLOGY, 33, 201, 10.1053/jhep.2001.20798
Sorbi, 1999, The ratio of aspartate aminotransferease to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease, Am J Gastroenterol, 94, 1018, 10.1111/j.1572-0241.1999.01006.x
Diehl, 1984, Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis, Gastroenterology, 86, 632, 10.1016/S0016-5085(84)80110-9
Ewing, 1984, Detecting alcoholism: the CAGE questionnaire, JAMA, 252, 1905, 10.1001/jama.1984.03350140051025
Selzer, 1971, The Michigan alcoholism screening test: the quest for a new diagnostic instrument, Am J Psychiatry, 127, 1653, 10.1176/ajp.127.12.1653
Pinto, 1996, Nonalcoholic steatohepatitis: clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients, Dig Dis Sci, 41, 172, 10.1007/BF02208601
Armstrong GL Wasley A Simard EP McQuillan GM Kuhnert WL Alter MJ The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Alter, 1999, The prevalence of hepatitis C virus infection in the United States, 1988 through 1994, N Engl J Med, 341, 556, 10.1056/NEJM199908193410802
Inglesby, 1999, A prospective community-based evaluation of liver enzymes in individuals with hepatitis C after drug use, HEPATOLOGY, 29, 590, 10.1002/hep.510290219
Conry-Cantilena, 1996, Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection, N Engl J Med, 334, 1691, 10.1056/NEJM199606273342602
Okanoue, 2005, A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase, J Hepatol, 43, 599, 10.1016/j.jhep.2005.04.008
Puoti, 1997, Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels, HEPATOLOGY, 26, 1393, 10.1002/hep.510260603
Nutt, 2000, Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels, Am J Med, 109, 62, 10.1016/S0002-9343(00)00381-8
Kyrlagkitsis, 2003, Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT, Am J Gastroenterol, 98, 1588, 10.1111/j.1572-0241.2003.07539.x
Margolis, 1995, Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations, JAMA, 274, 1201, 10.1001/jama.1995.03530150025029
Yuen, 2005, Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications, Gut, 54, 1610, 10.1136/gut.2005.065136
Yuen, 2003, A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy, Gut, 52, 416, 10.1136/gut.52.3.416
Green, 2002, AGA technical review on the evaluation of liver chemistry tests, Gastroenterology, 123, 1367, 10.1053/gast.2002.36061
Lohse, 1999, Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitis form of PBC genetically susceptible individuals, HEPATOLOGY, 29, 1078, 10.1002/hep.510290409
Ponsioen, 1998, Primary sclerosing cholangitis: a clinical review, Am J Gastroenterol, 93, 515, 10.1111/j.1572-0241.1998.157_b.x
Adams, 1991, Clinical presentation of hemochromatosis: a changing scene, Am J Med, 90, 445, 10.1016/0002-9343(91)90604-V
Summers, 1990, Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index, HEPATOLOGY, 12, 20, 10.1002/hep.1840120105
Crystal, 1990, ALpha-1 antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy, J Clin Invest, 85, 1343, 10.1172/JCI114578
Bardella, 1999, Chronic unexplained hypertransaminasemia may be caused by occult celiac disease, HEPATOLOGY, 29, 654, 10.1002/hep.510290318
Kim, 2004, Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study, BMJ, 328, 983, 10.1136/bmj.38050.593634.63
Kim, 2008, Serum aminotransferase activity and risk of mortality in a U. S. community population, HEPATOLOGY, 47
Ioannou, 2006, Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States, HEPATOLOGY, 43, 1145, 10.1002/hep.21171
Hanley, 2005, Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study, Diabetes, 54, 3140, 10.2337/diabetes.54.11.3140
1957, Commission on chronic illness: prevention of chronic illness (vol I). Chronic illness in the United States, 45
Wilson, 1968, Principles and practice of screening for disease
Kim, 2002, Burden of liver disease in the United States: summary of a workshop, HEPATOLOGY, 36, 227, 10.1053/jhep.2002.34734
Zaman, 1985, Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients, Lancet, 1, 1357, 10.1016/S0140-6736(85)91785-4
Parkin, 2001, Estimating the world cancer burden: Globocan 2000, Int J Cancer, 94, 153, 10.1002/ijc.1440
El-Serag, 2003, The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update, Annals of Internal Medicine, 139, 817, 10.7326/0003-4819-139-10-200311180-00009
El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001
Kim, 2005, Mortality and hospital utilization for hepatocellular carcinoma in the United States, Gastroenterology, 129, 486, 10.1016/j.gastro.2005.05.001